Dihydropseudoerythromycin derivatives
US8133871B2 · kind B2 · utility
0Cited by
1References
25Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 13, 2006 |
| Grant date | Mar 13, 2012 |
| Priority date | — |
| Expiry date | Oct 12, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P29/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound represented by the formula [I] wherein each symbol is as defined in the specification or a pharmacologically acceptable salt thereof, and a pharmaceutical composition containing the compound as an active ingredient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.